huC242-DM4
Term · Oncology and biomedicine · MLC-T-ONC-003998
A substance being studied in the treatment of some types of cancer. It is made by linking the monoclonal antibody huC242 to a toxic substance called maytansinoid DM4. The monoclonal antibody binds to the surfaces of cancer cells and the maytansinoid DM4 enters the cells and blocks their growth. It is a type of immunotoxin. Also called maytansinoid DM4-conjugated humanized monoclonal antibody huC242.
| Identifier | MLC-T-ONC-003998 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | maytansinoid DM4-conjugated humanized monoclonal antibody huC242 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-003998",
"term": "huC242-DM4",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of some types of cancer. It is made by linking the monoclonal antibody huC242 to a toxic substance called maytansinoid DM4. The monoclonal antibody binds to the surfaces of cancer cells and the maytansinoid DM4 enters the cells and blocks their growth. It is a type of immunotoxin. Also called maytansinoid DM4-conjugated humanized monoclonal antibody huC242.",
"expansions": [
"maytansinoid DM4-conjugated humanized monoclonal antibody huC242"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/huc242-dm4/"
}
Record 8,722 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.